Understand the story, not the spin.
Recent Verilumia coverage about Novartis AG (NVS), including reporting-tone insights and market listing information.
Novartis announced Tuesday that its experimental drug deldesiran has failed a pivotal late-stage clinical trial, marking the second significant setback for the Swiss pharmaceutical company's pipeline in less than a we...
Novartis shares surged on Tuesday after the Swiss pharmaceutical company announced positive results from two late-stage clinical trials of its oral multiple sclerosis drug, remibrutinib, showing it outperformed a riva...
Novartis has paused eight clinical trials of an experimental cell therapy for autoimmune and neurological diseases after three patients died from a severe immune reaction, a setback for a promising approach to treatin...
Verilumia 
